Acetylsalicylic acid Recruiting Phase 4 Trials for Acute Coronary Syndromes (ACS) / Coronary Artery Disease (CAD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03112707Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPT